EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adaptation of Aglycosylated Monoclonal Antibodies for Improved Production in Komagataella phaffii

Yuchen Yang iD, Neil C Dalvie iD, Joseph R Brady, Christopher A Naranjo, Timothy Lorgeree, Sergio A Rodriguez-Aponte iD, Ryan S Johnston, Mary K Tracey, Carmen M Elenberger, Eric Lee, Mark Tié, Kerry R Love und 1 weitere

Biotechnology and Bioengineering · 2025-02 · 122 (2) · 361-372

DOI: 10.1002/bit.28878 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 14.11.2024. Verfasst von Yuchen Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Saccharomycetales, Cricetulus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported partially by the AltHost Research Consortium and a project award from NIIMBL with financial support from the U.S. Department of Commerc…, National Institute for Innovation in Manufacturing Biopharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monoclonal antibodies (mAbs) are a major class of biopharmaceuticals manufactured by well‐established processes using Chinese Hamster Ovary (CHO) cells. Next‐generation biomanufacturing using alternative hosts like Komagataella phaffii could improve the accessibility of these medicines, address broad societal goals for sustainability, and offer financial advantages for accelerated development of new products. Antibodies produced by K. phaffii , however, may manifest unique molecular quality attributes, like host‐dependent, product‐related variants, that could raise potential concerns for clinical use. We demonstrate here conservative modifications to the amino acid sequence of aglycosylated antibodies based on the human IgG1 isotype that minimize product‐related variations when secreted by K. phaffii . A combination of 2–3 changes of amino acids reduced variations across six different aglycosylated versions of commercial mAbs. Expression of a modified sequence of NIST mAb in both K. phaffii and CHO cells showed comparable biophysical properties and molecular variations. These results suggest a path toward the production of high‐quality mAbs that could be expressed interchangeably by either yeast or mammalian cells. Improving molecular designs of proteins to enable a range of manufacturing strategies for well‐characterized biopharmaceuticals could accelerate global accessibility and innovations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalSaccharomycetalesCricetulusAnimalsCHO CellsGlycosylationHumansRecombinant ProteinsImmunoglobulin G

Stichwörter der Autor:innen

Pichia pastorisbiomanufacturingbiopharmaceuticalsfermentationyeast

Substanzen

Antibodies, MonoclonalRecombinant ProteinsImmunoglobulin G

Autor:innen und Institutionen

  • Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Biogen, Cambridge, Massachusetts, USA.

ORCID-Profile: Yuchen Yang, Neil C Dalvie, Sergio A Rodriguez-Aponte, J Christopher Love

Förderung

  • This work was supported partially by the AltHost Research Consortium and a project award from NIIMBL with financial support from the U.S. Department of Commerc…
  • National Institute for Innovation in Manufacturing Biopharmaceuticals

Zitieren

APA

Yang, Y., Dalvie, N. C., Brady, J. R., Naranjo, C. A., Lorgeree, T., Rodriguez-Aponte, S. A., Johnston, R. S., Tracey, M. K., Elenberger, C. M., Lee, E., Tié, M., Love, K. R., & Love, J. C. (2025). Adaptation of Aglycosylated Monoclonal Antibodies for Improved Production in Komagataella phaffii. Biotechnology and Bioengineering, 122(2), 361-372. https://doi.org/10.1002/bit.28878

Vancouver

Yang Y, Dalvie NC, Brady JR, Naranjo CA, Lorgeree T, Rodriguez-Aponte SA, et al. Adaptation of Aglycosylated Monoclonal Antibodies for Improved Production in Komagataella phaffii. Biotechnology and Bioengineering. 2025;122(2):361-372. doi:10.1002/bit.28878

BibTeX
@article{Yang2025,
  author = {Yang, Yuchen and Dalvie, Neil C and Brady, Joseph R and Naranjo, Christopher A and Lorgeree, Timothy and Rodriguez-Aponte, Sergio A and Johnston, Ryan S and Tracey, Mary K and Elenberger, Carmen M and Lee, Eric and Tié, Mark and Love, Kerry R and Love, J Christopher},
  title = {Adaptation of Aglycosylated Monoclonal Antibodies for Improved Production in Komagataella phaffii},
  journal = {Biotechnology and Bioengineering},
  year = {2025},
  volume = {122},
  number = {2},
  pages = {361--372},
  doi = {10.1002/bit.28878}
}
Kostenlos starten →